-
公开(公告)号:US20220372149A1
公开(公告)日:2022-11-24
申请号:US17662518
申请日:2022-05-09
申请人: AGENUS INC. , LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. , MEMORIAL SLOAN-KETTERING CANCER CENTER
发明人: Marc VAN DIJK , Cornelia Anne MUNDT , Gerd RITTER , Jedd David WOLCHOK , Taha MERGHOUB , Roberta ZAPPASODI , Rikke Baek HOLMGAARD , David SCHAER , David Adam SAVITSKY , Nicholas Stuart WILSON
IPC分类号: C07K16/28 , A61P35/00 , A61K45/06 , A61K39/395
摘要: The instant disclosure provides antibodies that specifically bind to human PD-1 and antagonize PD-1 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.